The cure STARTs here.

START Madrid is dedicated to the conduct of Phase I Clinical Trials of novel anticancer agents.

The mission of START Madrid is to accelerate the development of new anticancer drugs with the purpose of improving quality of life and survival for patients with cancer. START Madrid operates under the leadership of Dr. Emiliano Calvo, Dr. Ignacio Durán and Dr. Manuel Hidalgo and consists of a team of highly trained staff with extensive experience in Phase I clinical trials research.

Clinical Trials

New Hope for Patients. . . New Hope for a Cure

With centers located in Madrid, Spain and San Antonio, Texas, START conducts the world’s largest Phase I medical oncology program. Today, more than 50 percent of cancer patients can be cured with conventional treatments – that is, therapies with a proven response rate. However, there are many patients who do not respond to standard treatment and may be eligible for participation in our Phase I clinical trials program.

Clinical Research

START Madrid encompasses a superior team of supporting staff with extensive experience in oncology drug development and patient care.

Each department is held to the upmost of standards to ensure integrity and quality with a complete focus on our patients. Together these departments work toward fulfilling START Madrid’s mission to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer.